Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib) — Stella

Home/Inflammatory Disease/

View on ClinicalTrials.gov

Recruiting

Back to Inflammatory Disease trials

Trial locations(3 sites)

Portugal

Unidade Local de Saúde de Santo António, E.P.E., Porto

Unidade Local de Saúde de São João, E.P.E., Porto

Unidade Local de Saúde de Gaia/Espinho, E.P.E., Porto

Key details

Sponsor

Universidade do Porto

Collaborators

INFARMED - Autoridade Nacional do Medicamento e Produtos de Saúde, I.P., Unidade de Farmacovigilância do Porto

Enrollment target

~150 participants

Started

July 2024

Primary completion

October 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.